Results 21 to 30 of about 34,058 (241)

Simultaneous occurrence of medullary and papillary thyroid microcarcinomas: a case series and review of the literature

open access: yesJournal of Medical Case Reports, 2013
Introduction Papillary thyroid microcarcinoma has been demonstrated to present in association with medullary thyroid carcinoma, however, medullary thyroid carcinoma and papillary thyroid carcinoma represent rare entities.
Adnan Zaina   +4 more
doaj   +1 more source

A case report of diagnosis of liver metastasis of medullary thyroid carcinoma by multimodal ultrasound

open access: yesRadiology Case Reports, 2023
Medullary thyroid carcinoma is a rare malignant neuroendocrine tumor. Distant metastasis is difficult to detect early. It is most common in lung, liver, bone and brain.
Jie Xue, MD   +6 more
doaj   +1 more source

Medullary thyroid carcinoma

open access: yesExpert Review of Anticancer Therapy, 2023
Medullary thyroid carcinoma (MTC) constitutes approximately 5-10% of all thyroid cancers. Although the tumor forms in the thyroid, it doesn't originate from thyroid cells, but from the C cells or parafollicular cells which produce and release a hormone called calcitonin (CT). Starting from the second half of the 1900s, MTC was progressively studied and
Pelizzo, Maria Rosa   +3 more
openaire   +3 more sources

Synchronous mixed medullary‐papillary carcinoma and papillary multifocal carcinoma of the thyroid with cervical lymph node metastases

open access: yesClinical Case Reports, 2023
Key Clinical Message The occurrence of simultaneous multifocal papillary thyroid carcinoma and mixed medullary‐papillary carcinoma, as far as we know, has not been previously described.
Raquel Lalanda   +5 more
doaj   +1 more source

A Case of Mixed Medullary and Follicular Cell Carcinoma of the Thyroid [PDF]

open access: yes, 2011
A medullary thyroid carcinoma is a malignant tumor derived from the C-cells of the thyroid. Despite their distinct embryological origin, medullary thyroid carcinomas are exceptionally accompanied by a tumor derived from the follicular cells; this is ...
Ai Haraguchi   +17 more
core   +1 more source

Tumour-to-tumour metastasis: Rectal adenocarcinoma metastasis to medullary carcinoma of thyroid—Case report and review of the literature

open access: yesHuman Pathology Reports, 2022
Tumour-to-tumour metastasis is a rare incidence. Metastasis from colorectal cancer to primary thyroid neoplasm is extremely rare. We report a case of metastatic rectal adenocarcinoma to a medullary thyroid carcinoma.
Mahmoud Elsayed   +2 more
doaj   +1 more source

Three Cases of Medullary Thyroid Carcinoma in Our Hospital [PDF]

open access: yes, 2012
Medullary thyroid carcinoma (MTC) is a relatively rare phenomenon. We report three cases of MTC over the past 14years in our department. Two cases were determined out by hypercarcinoembryonic antigenemia, and one by hypercarcinoembryonic antigenemia and ...
春日, 好雄   +3 more
core   +1 more source

Breast metastasis from medullary thyroid carcinoma: a report of a case

open access: yesSurgical Case Reports, 2021
Background Metastasis to the breast is rare. We herein report a patient with metastatic medullary thyroid carcinoma to the breast for whom measuring the calcitonin level was an important clue to the correct diagnosis.
Yoko Omi   +6 more
doaj   +1 more source

Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumor with lymph node metastasis: A case report

open access: yesJournal of Medical Case Reports, 2011
Introduction Papillary thyroid carcinoma and medullary thyroid carcinoma are two different thyroid neoplasia. The simultaneous occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma as a collison tumor with metastases from both lesions
Sadat Alavi Mehr, Azarpira Negar
doaj   +1 more source

Mutations of the ret protooncogene in German multiple endocrine neoplasia families: Relation between genotype and phenotype. [PDF]

open access: yes, 1996
It has been suggested that not only the position but also the nature of the mutations of the ret protooncogene strongly correlate with the clinical manifestation of the multiple endocrine neoplasm type 2 (MEN 2) syndrome.
Rendl, J.   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy